NKTR nektar.com: Rasio rega marang prakiraan pendapatan

Logo korporat perusahaan Nektar Therapeutics Inc (NKTR)

The forward price-to-sales valuation of Nektar Therapeutics (NKTR) reflects market expectations for a scalable pegylation model, where licensing molecules to Big Pharma generates net income without the overhead of manufacturing plants. Business success is predicated on patent protection and joint research with industry behemoths. Currently, 24.40 represents the latest metric reading, capturing a period of rigorous R&D pipeline renewal following a series of setbacks.

Nektar Therapeutics Inc. - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep NKTR (periode 04.07.2022 - 16.11.2026)

Rincian analitis perusahaan Nektar Therapeutics (NKTR)

- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
Analisis fundamental perusahaan:NKTR (Nektar)
Produk sing diprodhuksi Nektar Corp

Forward P/S measures a company's market value relative to expected sales volume, reflecting investor expectations regarding growth rates. Forward P/S dynamics allow for an assessment of the cost of capital's impact on the asset's capitalization. The metric is calculated as the ratio of the current share price to the projected revenue per share. For Nektar Therapeutics (NKTR), this indicator demonstrates how the market values the potential of their unique polymer conjugate platform.

Pesaing wigati

Multiplikator Forward P/S ARGX (argenx.com)|BioNTech Group (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ABIVAX - Multiplikator Forward P/S|ADMA - Multiplikator Forward P/S|Protagonist (PTGX) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Immunovant Inc|Rasio rega marang prakiraan pendapatan Kiniksa Pharmaceuticals|Grifols Group (GRFS) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Adaptive Biotechnologies Corp (ADPT)|Rasio rega marang prakiraan pendapatan CLDX (Celldex Therapeutics)|Rasio rega marang prakiraan pendapatan Aurinia Pharma AUPH|Rega forward marang dodolan BCRX|VERA: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan DNTH (Dianthus Therapeutics)|Pharvaris N.V. (PHVS) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep AbCellera Biologics (ABCL)|TRML (Tourmaline Bio Inc) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PGEN (Intrexon)|Multiplikator forward rega marang pendapatan PHAR (Pharming)|Rasio rega marang prakiraan pendapatan UPB (Upstream Bio Corp)|Rasio rega marang prakiraan pendapatan Zenas Biopharma, Inc. ZBIO|Rasio kapitalisasi marang dodolan sing dikarepake immunome.com (IMNM)|Gossamer Bio Inc - Multiplikator Forward P/S|Rega forward marang dodolan KALV (KalVista Pharmaceuticals, Inc.)|SEPN: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Pieris Pharmaceuticals Inc|Multiplikator forward rega marang pendapatan SVRA|Multiplikator forward rega marang pendapatan Rigel Pharmaceuticals (RIGL)|Multiplikator Forward P/S ANAB|ATXS - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan enGene Corp ENGN|Rasio kapitalisasi marang dodolan sing dikarepake RAPT Therapeutics, Inc. (RAPT)|Aerovate - Multiplikator Forward P/S|ACRS - Multiplikator Forward P/S|KYTX (Kyverna Therapeutics) - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Tiziana Life Sciences Ltd. (TLSA)|Multiplikator forward rega marang pendapatan CABA|Ventyx Biosciences (VTYX) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S THTX|AVTX (Avalo Therapeutics, Inc) - Rega forward marang dodolan|Multiplikator Forward P/S ELDN (eledon.com)|AGEN - Multiplikator forward rega marang pendapatan|CLYM - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan ZURA|ATYR: Multiplikator Forward P/S|Adagene Corp (ADAG) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan IMA|Shattuck Labs, Inc. - Rega mangsa ngarep marang pendapatan|Rasio rega marang prakiraan pendapatan Equillium Inc (EQ)|Multiplikator Forward P/S Connect Biopharma Holdings (CNTB)|Rasio rega marang prakiraan pendapatan Immunic, Inc. IMUX|Multiplikator Forward P/S Atara Biotherapeutics ATRA|IFRX - Rasio rega marang prakiraan pendapatan|XFOR: Rasio rega marang prakiraan pendapatan|ACET: Multiplikator Forward P/S|CELU - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan inmunebio.com|Kapitalisasi marang prakiraan pendapatan BRNS (barinthusbio.com)|Multiplikator Forward P/S KZR|Multiplikator Forward P/S SAB Biotherapeutics, Inc (SABS)|Multiplikator Forward P/S AKTX (Akari Therapeutics, Plc)|Multiplikator Forward P/S enlivex.com ENLV|QTTB: Multiplikator forward rega marang pendapatan|GOVX - Multiplikator Forward P/S|Edesa Biotech Inc (EDSA) - Rasio rega marang prakiraan pendapatan|IBIO - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan carismatx.com|XTLB: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Bolt Biotherapeutics Inc. (BOLT)|HCW Biologics - Kapitalisasi marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan aptevotherapeutics.com APVO|AIM - Multiplikator forward rega marang pendapatan|Aditxt - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake GRI Bio Corporation GRI|xortx.com (XRTX) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep reshapelifesciences.com (HIND)|Rasio rega marang prakiraan pendapatan Revelation Bio|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Indaptus Therapeutics, Inc. INDP|Rasio rega marang prakiraan pendapatan BiondVax Pharmaceuticals (SCNI)|Multiplikator forward rega marang pendapatan CalciMedica CALI|Rasio rega marang prakiraan pendapatan Affimed AFMD|ALLK - Multiplikator forward rega marang pendapatan|HOOKIPA Pharma, Inc. - Multiplikator Forward P/S|Rega forward marang dodolan IGMS (igmbio.com)|ITOS (iTeos Therapeutics, Inc.) - Multiplikator forward rega marang pendapatan|Ocean Biomedical Corp (OCEA) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan TC BioPharm (Holdings) PLC|Multiplikator Forward P/S thirdharmonicbio.com